New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: Travel time between Rayagada and Kereda in southern Odisha is expected to nearly halve…
Bhubaneswar: In a major push to expand irrigation in water-deficit parts of Odisha, the state…
Bhubaneswar: Odisha is set to invest Rs 650 crore over the next five years to…
Bhubaneswar: Odisha is set to strengthen its agriculture administration with more officers at the senior,…
Bhubaneswar: The Odisha government has decided to digitise and integrate old records of Bhoodan land…
Bhubaneswar: The Odisha government is set to undertake another round of regulatory reforms aimed at…
